• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回顾过去,展望未来:当前治疗酒精使用障碍的药物和创新潜在药物。

Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder.

机构信息

Pearson Center for Alcoholism and Addiction Research, Department of Molecular Medicine, Scripps Research Institute, La Jolla, California.

出版信息

Alcohol Res. 2022 Oct 20;42(1):11. doi: 10.35946/arcr.v42.1.11. eCollection 2022.

DOI:10.35946/arcr.v42.1.11
PMID:36320345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9595448/
Abstract

This article is part of a Festschrift commemorating the 50th anniversary of the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Established in 1970, first as part of the National Institute of Mental Health and later as an independent institute of the National Institutes of Health, NIAAA today is the world's largest funding agency for alcohol research. In addition to its own intramural research program, NIAAA supports the entire spectrum of innovative basic, translational, and clinical research to advance the diagnosis, prevention, and treatment of alcohol use disorder and alcohol-related problems. To celebrate the anniversary, NIAAA hosted a 2-day symposium, "Alcohol Across the Lifespan: 50 Years of Evidence-Based Diagnosis, Prevention, and Treatment Research," devoted to key topics within the field of alcohol research. This article is based on Dr. Mason's presentation at the event. NIAAA Director George F. Koob, Ph.D., serves as editor of the Festschrift.

摘要

这篇文章是为纪念国家酒精滥用和酒精中毒研究所(NIAAA)成立 50 周年而撰写的专刊的一部分。NIAAA 成立于 1970 年,最初是国家心理健康研究所的一部分,后来成为美国国立卫生研究院的一个独立机构。如今,NIAAA 是世界上最大的酒精研究资助机构。除了自己的内部研究计划外,NIAAA 还支持从基础研究到转化研究再到临床研究的各个方面,以推进酒精使用障碍和与酒精相关问题的诊断、预防和治疗。为了庆祝周年纪念,NIAAA 举办了为期两天的研讨会,主题为“一生中的酒精:50 年基于证据的诊断、预防和治疗研究”,专门讨论酒精研究领域的关键主题。本文基于 Mason 博士在该活动上的演讲。NIAAA 主任 George F. Koob,博士,担任专刊的编辑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae74/9595448/29dff5a4edd1/ARCR-42-1-Article11_Mason_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae74/9595448/29dff5a4edd1/ARCR-42-1-Article11_Mason_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae74/9595448/29dff5a4edd1/ARCR-42-1-Article11_Mason_Figure1.jpg

相似文献

1
Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder.回顾过去,展望未来:当前治疗酒精使用障碍的药物和创新潜在药物。
Alcohol Res. 2022 Oct 20;42(1):11. doi: 10.35946/arcr.v42.1.11. eCollection 2022.
2
Alcohol Use Disorder and Alcohol-Associated Liver Disease.酒精使用障碍与酒精相关肝病。
Alcohol Res. 2022 Nov 10;42(1):13. doi: 10.35946/arcr.v42.1.13. eCollection 2022.
3
AUD Risk, Diagnoses, and Course in a Prospective Study Across Two Generations: Implications for Prevention.两代人群中的 AUD 风险、诊断和病程:预防意义。
Alcohol Res. 2022 Jan 6;42(1):01. doi: 10.35946/arcr.v42.1.01. eCollection 2022.
4
Alcohol's Negative Emotional Side: The Role of Stress Neurobiology in Alcohol Use Disorder.酒精的负面情绪影响:应激神经生物学在酒精使用障碍中的作用。
Alcohol Res. 2022 Oct 27;42(1):12. doi: 10.35946/arcr.v42.1.12. eCollection 2022.
5
Fetal Alcohol Spectrum Disorders: Awareness to Insight in Just 50 Years.胎儿酒精谱系障碍:50 年内的认识到洞察。
Alcohol Res. 2022 Feb 24;42(1):05. doi: 10.35946/arcr.v42.1.05. eCollection 2022.
6
Alcohol and the Adolescent Brain: What We've Learned and Where the Data Are Taking Us.酒精与青少年大脑:我们的所知所得及数据指向之处。
Alcohol Res. 2022 Apr 7;42(1):07. doi: 10.35946/arcr.v42.1.07. eCollection 2022.
7
Age, Period, and Cohort Effects in Alcohol Use in the United States in the 20th and 21st Centuries: Implications for the Coming Decades.20 世纪和 21 世纪美国饮酒的年龄、时期和队列效应:对未来几十年的影响。
Alcohol Res. 2022 Jan 13;42(1):02. doi: 10.35946/arcr.v42.1.02. eCollection 2022.
8
NIAAA: advancing alcohol research for 40 years.美国国家酒精滥用与酒精中毒研究所:40年来推动酒精研究发展。
Alcohol Res Health. 2010;33(1-2):5-17.
9
Advances in Pharmacotherapy Development: Human Clinical Studies.药物治疗研发进展:人体临床研究
Handb Exp Pharmacol. 2018;248:579-613. doi: 10.1007/164_2017_79.
10
Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.用于治疗酒精使用障碍的潜在药物:临床疗效与安全性评估。
Subst Abus. 2016 Apr-Jun;37(2):286-98. doi: 10.1080/08897077.2015.1133472.

引用本文的文献

1
An inhibitory GLP-1 circuit in the lateral septum modulates reward processing and alcohol intake in rodents.外侧隔区中的抑制性胰高血糖素样肽-1回路调节啮齿动物的奖赏处理和酒精摄入。
EBioMedicine. 2025 May;115:105684. doi: 10.1016/j.ebiom.2025.105684. Epub 2025 Apr 17.
2
Design and Characterization of Chitosan-Based Smart Injectable Hydrogel for Improved Sustained Release of Antinarcotics.用于改善抗麻醉药持续释放的壳聚糖基智能可注射水凝胶的设计与表征
Pharmaceuticals (Basel). 2024 Jun 7;17(6):749. doi: 10.3390/ph17060749.
3
µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice.

本文引用的文献

1
Alcohol-Related Deaths During the COVID-19 Pandemic.新冠大流行期间与酒精相关的死亡。
JAMA. 2022 May 3;327(17):1704-1706. doi: 10.1001/jama.2022.4308.
2
Use of Medications for Alcohol Use Disorder in the US: Results From the 2019 National Survey on Drug Use and Health.美国酒精使用障碍药物的使用情况:2019年全国药物使用和健康调查结果
JAMA Psychiatry. 2021 Jun 16;78(8):922-4. doi: 10.1001/jamapsychiatry.2021.1271.
3
Alcohol Use Disorder: The Role of Medication in Recovery.酒精使用障碍:药物在康复中的作用。
μ-阿片受体拮抗作用促进催产素在小鼠体内产生抗焦虑样作用。
Transl Psychiatry. 2024 Feb 28;14(1):125. doi: 10.1038/s41398-024-02830-1.
4
Pharmacological GHSR (ghrelin receptor) blockade reduces alcohol binge-like drinking in male and female mice.药理学 GHSR(生长激素释放肽受体)阻断可减少雄性和雌性小鼠的酒精 binge-like 样饮酒。
Neuropharmacology. 2023 Nov 1;238:109643. doi: 10.1016/j.neuropharm.2023.109643. Epub 2023 Jun 25.
5
NIAAA 50th Anniversary Festschrift: From the Editor.美国国立酒精滥用与酒精中毒研究所成立50周年纪念文集:来自编辑的话。
Alcohol Res. 2022 Nov 17;42(1):14. doi: 10.35946/arcr.v42.1.14. eCollection 2022.
Alcohol Res. 2021 Jun 3;41(1):07. doi: 10.35946/arcr.v41.1.07. eCollection 2021.
4
Drug Overdose Deaths in the United States, 1999-2017.1999 - 2017年美国药物过量致死情况
NCHS Data Brief. 2018 Nov(329):1-8.
5
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study.新型生长激素释放肽受体反向激动剂 PF-5190457 联合酒精给药:临床前安全性实验和 1b 期人体实验室研究。
Mol Psychiatry. 2020 Feb;25(2):461-475. doi: 10.1038/s41380-018-0064-y. Epub 2018 May 4.
6
Trends in Alcohol-Related Emergency Department Visits in the United States: Results from the Nationwide Emergency Department Sample, 2006 to 2014.美国与酒精相关的急诊就诊趋势:来自 2006 年至 2014 年全国急诊抽样调查的结果。
Alcohol Clin Exp Res. 2018 Feb;42(2):352-359. doi: 10.1111/acer.13559. Epub 2018 Jan 2.
7
Gabapentin for the treatment of alcohol use disorder.加巴喷丁用于治疗酒精使用障碍。
Expert Opin Investig Drugs. 2018 Jan;27(1):113-124. doi: 10.1080/13543784.2018.1417383. Epub 2017 Dec 23.
8
Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder.甲基化组谱分析和复制表明 PCSK9 失调与酒精使用障碍有关。
Mol Psychiatry. 2018 Sep;23(9):1900-1910. doi: 10.1038/mp.2017.168. Epub 2017 Aug 29.
9
Drinking Beyond the Binge Threshold: Predictors, Consequences, and Changes in the U.S.饮酒超过 binge 阈值:美国的预测因素、后果和变化
Am J Prev Med. 2017 Jun;52(6):717-727. doi: 10.1016/j.amepre.2017.02.014.
10
A relationship between the aldosterone-mineralocorticoid receptor pathway and alcohol drinking: preliminary translational findings across rats, monkeys and humans.醛固酮-盐皮质激素受体通路与饮酒行为的关系:大鼠、猴子和人类的初步转化研究发现。
Mol Psychiatry. 2018 Jun;23(6):1466-1473. doi: 10.1038/mp.2017.97. Epub 2017 May 2.